Welcome to the 96th edition of Deep Tech Catalyst, the educational channel from The Scenarionist where science meets venture!
Food technology sits at a pivotal point in the Deep Tech landscape. Once confined to the lab, it now stands on the edge of large-scale commercialization, with founders racing to translate scientific breakthroughs into viable products that can transform the global food system.
But will these companies be able to scale at the right speed?
To unpack what it really takes to cross that threshold—from de-risked science to market-ready scale—we’re joined by Steve Molino, Principal at Synthesis Capital.
Key takeaways from the episode (TL;DR):
🌱 Series A is the inflection point
- The shift from proving the science to proving the business.
- Technology must be de-risked, with a credible path to scale.
📈 Conviction without revenue is possible
- Investors look for validated pain points, not just LOIs.
- Demand has to be tied to supply stability, nutrition, or cost—not only sustainability.
🏭 B2B dominates early-stage food tech
- Consumer brands require entirely different capital and teams.
- Ingredients and platforms play show faster paths to traction.
⚖️ Regulation defines market entry
- Singapore, the U.S., and Australia are leading; Europe is cautious.
- First movers build the framework—fast followers benefit from it.
💡 Capital efficiency is survival
- Use interim markets to generate early revenue.
- Outsource manufacturing before investing in facilities.
✨ For more, see Membership | Deep Tech Briefing | Insights | VC Guides
